Create Free Account

By creating account you will get access to hot stocks & personalised emails

Trajan Group Holdings Ltd

Healthcare AU TRJ

0.99AUD
0.03(2.59%)

Last update at 2024-05-16T00:00:00Z

Day Range

0.981.03
LowHigh

52 Week Range

0.681.91
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax 5.47M 2.25M 1.90M 2.99M 2.98M
Minority interest - - - - -
Net income 1.89M 1.70M 1.88M 2.61M 2.14M
Selling general administrative 47.70M 31.82M 25.89M 21.39M 20.88M
Selling and marketing expenses - 0.69M 0.12M - -
Gross profit 67.09M 42.63M 28.48M 24.35M 25.18M
Reconciled depreciation 5.36M 1.63M 1.04M - -
Ebit 9.43M 2.91M 2.08M 1.47M 2.95M
Ebitda 14.16M 4.54M 3.12M - -
Depreciation and amortization - 1.63M 1.04M - -
Non operating income net other - - - - -
Operating income 9.43M 2.91M 2.08M 1.47M 2.95M
Other operating expenses 0.45M 101.95M 76.78M 0.15M 0.15M
Interest expense 3.32M 0.66M 0.17M 0.00000M 0.00000M
Tax provision 3.59M 0.55M 0.02M 0.38M 0.83M
Interest income 0.01M 0.00200M 0.07M 0.20M 0.20M
Net interest income -4.00200M -1.26500M -0.52200M - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 3.59M 0.55M 0.02M 0.38M 0.83M
Total revenue 162.15M 107.57M 76.57M 71.85M 67.77M
Total operating expenses - 37.01M 28.70M - -
Cost of revenue 95.06M 64.94M 48.08M 47.50M 42.59M
Total other income expense net 0.05M -2.10700M 2.64M - -
Discontinued operations - - - - -
Net income from continuing ops 1.89M 1.70M 1.88M - -
Net income applicable to common shares 1.89M 1.70M 1.88M 2.61M 2.14M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 229.04M 206.78M 99.38M 44.20M 40.99M
Intangible assets 33.68M 3.98M 1.09M 0.77M 0.00000M
Earning assets - - - - -
Other current assets 0.33M 0.03M 1.51M 1.01M 0.02M
Total liab 99.51M 90.27M 33.30M 26.45M 24.98M
Total stockholder equity 129.53M 116.51M 66.08M 17.74M 16.02M
Deferred long term liab - - - - -
Other current liab 3.92M 15.20M 10.57M 1.79M 2.51M
Common stock 101.25M 96.26M 48.17M 0.00300M 0.00300M
Capital stock 101.25M 96.26M 48.17M - -
Retained earnings 18.62M 17.33M 15.62M 17.09M 14.81M
Other liab 10.77M 0.32M 0.60M 0.69M 1.70M
Good will 80.57M 103.43M 1.09M - 0.77M
Other assets 6.61M 4.34M 4.89M 4.88M 5.20M
Cash 11.04M 13.16M 51.72M 0.85M 0.96M
Cash and equivalents - 0.89M 0.75M 0.85M 0.96M
Total current liabilities 39.20M 80.15M 24.11M 18.12M 18.78M
Current deferred revenue - - - - -
Net debt 37.59M 53.02M -34.69700M - -
Short term debt - 56.38M 8.43M 0.00000M 0.00000M
Short long term debt 9.93M 54.84M 7.29M - -
Short long term debt total - 66.18M 17.02M 7.64M 4.50M
Other stockholder equity 9.66M 2.92M 2.29M 0.64M 1.21M
Property plant equipment 35.22M 27.61M 14.26M 8.65M 5.04M
Total current assets 69.71M 64.86M 78.54M 29.11M 28.90M
Long term investments 1.55M 1.46M 0.21M - -
Net tangible assets 13.57M 8.01M 64.59M 16.39M 14.38M
Short term investments - - 0.75M 0.99M -
Net receivables 24.16M 20.75M 10.33M 7.41M 9.62M
Long term debt 38.71M 0.00000M 0.00000M 4.29M 4.50M
Inventory 31.93M 28.27M 13.57M 14.64M 13.99M
Accounts payable 9.58M 8.57M 5.11M 2.08M 6.04M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 2.92M 2.29M - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 159.33M 141.91M 20.84M - -
Capital lease obligations 12.67M 11.34M 9.73M - -
Long term debt total - 9.80M 8.59M 7.64M 4.50M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -8.55300M -1.31300M 2.61M 2.61M -0.41100M
Change to liabilities 2.61M 1.60M 1.95M -1.46900M 2.48M
Total cashflows from investing activities -8.55300M -116.38200M 0.40M -0.79700M -3.05600M
Net borrowings -7.89100M 45.58M -3.13800M -0.23600M 0.40M
Total cash from financing activities -3.36400M 74.69M 36.81M -0.23600M 0.40M
Change to operating activities 1.06M 1.51M 0.24M -1.04500M 0.94M
Net income 1.89M 1.70M 1.88M 2.61M 2.14M
Change in cash -2.12600M -38.55300M 46.93M 0.80M 0.44M
Begin period cash flow 13.16M 51.72M 4.79M - -
End period cash flow 11.04M 13.16M 51.72M 4.79M -
Total cash from operating activities 9.55M 2.74M 9.86M 1.76M 2.84M
Issuance of capital stock 4.71M 29.97M 50.00M - -
Depreciation 7.90M 3.64M 3.02M 3.18M 1.75M
Other cashflows from investing activities - -112.96700M 1.51M 0.00000M -0.38100M
Dividends paid - -49.21500M -3.35000M 3.35M 3.35M
Change to inventory -3.59700M -4.72000M 1.18M -0.09500M -4.37800M
Change to account receivables -3.17400M -2.47100M -3.53700M 2.27M -1.50500M
Sale purchase of stock -0.18100M -0.85700M -7.11200M - -
Other cashflows from financing activities -0.18100M 47.27M -1.18300M -7.11200M -7.11200M
Change to netincome 1.61M 2.41M 4.13M -2.32800M 0.05M
Capital expenditures 8.55M 3.42M 1.11M 0.80M 2.67M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - -101.40900M -61.58800M -70.91300M -63.95000M
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow 1.00M -3.41500M -1.10600M - -

Fundamentals

  • Previous Close 0.96
  • Market Cap150.69M
  • Volume190541
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA10.41M
  • Revenue TTM158.50M
  • Revenue Per Share TTM1.04
  • Gross Profit TTM 65.68M
  • Diluted EPS TTM-0.01

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
TRJ
Trajan Group Holdings Ltd		 0.03 2.59% 0.99 - 45.45 1.22 1.55 1.53 28.06
RMD
Resmed Inc DRC		 0.44 1.35% 33.14 33.78 23.87 9.54 6.24 9.91 31.23
FPH
Fisher & Paykel Healthcare Corporation Limited		 0.48 1.84% 26.54 65.12 44.84 8.32 8.72 8.36 30.31
ANN
Ansell Ltd		 0.25 0.97% 26.05 21.48 11.44 2.31 1.54 2.63 18.75
NAN
Nanosonics Ltd		 0.12 4.14% 3.02 60.20 67.11 5.32 4.97 4.62 32.66

Reports Covered

Stock Research & News

View All

Profile

Trajan Group Holdings Limited develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India. It operates through Analytical Products and Life Science Solutions segments. The company offers analytical products, including syringes, GC columns and connections, rings, inlet liners, emitters, purifiers and filters, and tubing products; pathology products, such as NBF containers, adhesive and frosted microscope slides, coverslips, slide storage trays/mailers, cassette storage boxes, biopsy pads, histology wax plus, microtome blades, and marking dyes and sets, as well as MiPlatform, a smartphone adapter. It also provides sampling products, comprising septa, caps, liners, crimping tools, well plates and sealing mats, and micro sampling tools, as well as automation systems for the analysis of biological, food, and environmental samples. In addition, the company offers automation workflow solutions, micro sampling devices, testing, and data analysis services. Trajan Group Holdings Limited was incorporated in 2011 and is headquartered in Ringwood, Australia.

Trajan Group Holdings Ltd

7 Argent Place, Ringwood, VIC, Australia, 3134

Key Executives

Name Title Year Born
Mr. Stephen Tomisich CEO, MD & Director NA
Mr. Alister John Hodges CPA, CPA CFO & Company Sec. NA
Mr. Nigel Gilligan Chief Operations Officer NA
Dr. Andrew Arthur Gooley Chief Scientific Officer NA
Mr. Robert Lyon Exec. Director, Head of Corp. Devel. & Gen. Counsel NA
Mr. Sam Evans Sr. VP of Bus. Devel. NA
Ms. Helene Lajoie Chief HR Officer NA
Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSP Joint Company Sec. 1964
Mr. Alister John Hodges CPA, CPA CFO & Company Secretary NA
Mr. Robert Lyon Executive Director, Head of Corporate Development & General Counsel NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Our Company

Useful Links

Contact Us

Market Research

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.